MICHAEL R. BRISTOW

Insider Reports History

Signature
/s/ C. Jeffrey Dekker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MICHAEL R. BRISTOW:

Company Role Class Num Shares Value Price $ Report Date Ownership
ARCA biopharma, Inc. Pres. & Chief Executive Offic, Director Common Stock 2,285 $5,713 $2.50 14 Dec 2021 Direct
ARCA biopharma, Inc. Pres. & Chief Executive Offic, Director Common Stock 1,414 $3,535 $2.50 14 Dec 2021 By NFS Custodian for Michael Bristow's IRA
ARCA biopharma, Inc. Pres. & Chief Executive Offic, Director Common Stock 1,109 $2,773 $2.50 14 Dec 2021 By InvestocorTrust as sole Trustee
ARCA biopharma, Inc. Pres. & Chief Executive Offic, Director Stock Option (right to buy) 95,000 14 Dec 2021 Direct

Insider Reports Filed by MICHAEL R. BRISTOW

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ORKA ARCA biopharma, Inc. 14 Dec 2021 1 $0 4 Pres. & Chief Executive Offic, Director 16 Dec 2021, 15:31